lobbying_activities: 2781986

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2781986	09b0f0d2-4d8c-4dd2-a709-a87722be8a80	1T	MEHLMAN CONSULTING, INC.	284950	AMNEAL	2022	first_quarter	PHA	Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs. Pandemic Preparedness. H.R. 5376 - Build Back Better Act. S. 3799 - PREVENT Pandemics Act.	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	40000		0	1	2022-04-19T09:38:06-04:00